ISSN: 2476-2075

検眼: オープンアクセス

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

How Do We Enhance Glaucoma Screening and Reduce Glaucoma Related Blindness?

Annamalai Odayappan, Srinivasan Kavitha, Sivagami Nachiappan, Rengaraj Venkatesh

Glaucoma is the leading cause of irreversible blindness and this burden has been projected to increase significantly in the years to come.Therefore, various steps need to be taken to tackle this problem and reduce the magnitude of blindness in the community. Screening the general population may not be feasible for glaucoma due to various reasons. This implies that we need to know who the high-risk population is so that we can do a targeted screening. The various risk factors described to be associated with delayed presentation includes older age, African-Caribbean individuals, female gender, socio-economic deprivation, poor literacy, unemployment, rural residence-greater distance from the hospital, patients referred by non-optometrists and presentation with symptoms.The prevalence of primary glaucomas is also greater among family members of known glaucoma patients. An appropriate action would be to screen people with such high-risk factors and thus diagnose glaucoma early. The other major concerns include maintaining patient’s compliance to treatment and identification of progression early. Detailed oral counselling and use of modern technology to create awareness have been suggested as aids in maintaining the follow-up. Here, we review the ways of how we could enhance glaucoma screening and maintain long-term follow up, patient care.